Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT06176144 Recruiting - Delirium Clinical Trials

Impact of Desflurane and Sevoflurane on Postoperative Delirium in Elderly Patients

Start date: September 10, 2023
Phase: N/A
Study type: Interventional

Advanced age is a consistent risk factor for the incidence of postoperative cognitive decline, which is associated with longer hospital stays, decreased quality of life, and increased mortality. Anaesthetic drugs can also affect postoperative cognition, as their residual effects can alter central nervous system activity. Desflurane and sevoflurane are widely used volatile anesthetics. Choice anesthetics may influence the occurrence of postoperative delirium. However, evidence in this aspect is conflicting.

NCT ID: NCT06172491 Recruiting - Delirium Clinical Trials

Automating Delirium Severity in the ICU

ADS-ICU
Start date: January 15, 2023
Phase:
Study type: Observational

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients >50 years of age. The main questions it aims to answer are: - Is the trained convolutional neural network able to reliably measure delirium severity. - Is the Passive Digital Marker able to accurately measure delirium severity - Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers). Participants will: - Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). - Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.

NCT ID: NCT06161480 Recruiting - Delirium Clinical Trials

Feasibility and Acceptability of Using Weighted Blankets to Prevent and /or Mitigate Delirium

Start date: October 6, 2023
Phase: N/A
Study type: Interventional

The use of weighted blankets to avert or alleviate Delirium in Adult ICU patients.

NCT ID: NCT06150339 Recruiting - Dementia Clinical Trials

Older Adults With Cognitive Impairment Doing Sit to Stands, Walking in Transitional Care Programs: A Feasibility Study

OASIS
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The goal of this intervention study is to test the effects of a nurse-led mobility intervention (known as the OASIS Walking Intervention (Older Adults performing Sit to Stands and Walking Intervention)) in older adults with cognitive impairment, such as dementia, in transitional care programs. The main questions this study aims to answer are: - Is the study doable and are older adults satisfied with the intervention? - Does the intervention improve older adults' muscle strength, mobility, functional status and quality of life? Participants will be asked to do the following: 1. Be interviewed once so that a patient-centred communication care plan can be made 2. Do sit to stand activity 3. Walk as part of a walking program.

NCT ID: NCT06115031 Recruiting - Clinical trials for Postoperative Delirium

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anestheisa (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.

NCT ID: NCT06100029 Recruiting - Delirium in Old Age Clinical Trials

The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Elderly critically ill patients in the intensive care unit (ICU) are at risk of delirium, which is primarily characterized by acute consciousness impairment and perceptual, cognitive, and memory impairment, resulting in excess death, care expenditures, and acquired dementia, depression and anxiety, which severely affect the prognosis of critically ill patients. However, there are currently no effective pharmacological strategies for preventing delirium. Inhalation aromatherapy has been proven to benefits the sleep disorder, anxiety or depression and lavender oil is one of the most used essential oils. Therefore, we hypothesized that the use of lavender would reduce the incidence rate of delirium in ICU patients.

NCT ID: NCT06090955 Recruiting - Clinical trials for Delirium, Postoperative

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

Start date: October 25, 2023
Phase: N/A
Study type: Interventional

Postoperative delirium (POD) is the most common complications (~50-60%) in elderly and major challenges to our rapidly growing aging population. Growing evidence suggests a possible role for neuroinflammation in the development of delirium, which is facilitated by a transient increase in blood-brain barrier (BBB) permeability. Lidocaine and dexmedetomidine, commonly used anesthetic adjuncts, have anti-inflammatory properties. Both drugs are reported to have modulatory effect on the intergrity of BBB and associated with a beneficial effect on postoperative neurocognitive dysfunction. In this regard, The investigators aimed to prospectively compare the modulatory effect of the intraoperative administration of dexmedetomidine or lidocaine with a sham control group (normal saline solution) on surgery-induced BBB disruption.

NCT ID: NCT06082024 Recruiting - Clinical trials for Postoperative Delirium

Correlation Between Perioperative EEG Features and Delirium After General Anesthesia

Start date: April 13, 2023
Phase:
Study type: Observational

The goal of this observational study is to compare the perioperative EEG characteristics and the incidence of short-term cognitive dysfunction in patients with postoperative delirium and non-postoperative delirium after elderly (> 65 years old) patients undergoing major gastrointestinal surgery under general anesthesia. The main question it aims to answer are: • The correlation between postoperative cognitive dysfunction and postoperative EEG features was evaluated.• To analyze the correlation between EEG characteristics and clinical risk factors of delirium after major abdominal gastrointestinal surgery under general anesthesia in elderly patients.Participants will collect EEG before and after operation and collect the incidence of postoperative cognitive function to explore the mechanism of postoperative delirium and predict postoperative cognitive dysfunction.

NCT ID: NCT06076668 Recruiting - Delirium Clinical Trials

Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Delirium

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

This study aims to compare the effect of dexmedetomidine infusion and oral melatonin on preventing delirium in intensive care unit (ICU) patients.

NCT ID: NCT06071793 Recruiting - Critical Illness Clinical Trials

Family Integration in Therapy Activities in the Intensive Care Unit: The FIT-ICU Feasibility Study

FIT-ICU
Start date: November 30, 2023
Phase: N/A
Study type: Interventional

An ICU admission is stressful for not only patients but their families as well. Research has shown that involving family members during a loved one's ICU stay can be helpful for them, but there is not clear direction on the best way to do this. For patients, family presence as well as early movement during their ICU stay has been shown to help recovery from things like delirium (a state of confusion) faster, and might prevent the weakness that can happen with a stay in the ICU. In this study, the investigators will explore whether having family help with moving patients through physiotherapy guided exercise can help both patients and families have a better experience and result from their ICU stay. The investigators hypothesize that family involvement in activities as part of an overall physiotherapy treatment plan will provide a tangible means for family members to engage in the care of their critically ill loved one, thus improving outcomes for both critically ill patients and family members.